Vitamin K status and cognitive function in healthy older adults

Neurobiology of Aging

Volumn 34, Issue 12, 2013, Pages 2777-2783

  Presse, Nancy ^a,b   Belleville, Sylvie ^a,b   Gaudreau, Pierrette ^b,c   Greenwood, Carol E ^d   Kergoat, Marie Jeanne ^a,b   Morais, Jose A ^e   Payette, Hélène ^f   Shatenstein, Bryna ^a,b   Ferland, Guylaine ^a,b  

^a CENTRE DE RECHERCHE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d Kunin Lunenfeld Applied Research Unit and Department of Food and Nutrition Services and Baycrest Centre for Geriatric Care   (Canada)

^e MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^f UNIVERSITY INSTITUTE OF GERIATRICS OF SHERBROOKE   (Canada)

Author keywords

Aging; Cognition; Phylloquinone; Vitamin K

Indexed keywords

PHYTOMENADIONE; VITAMIN K GROUP;

AGED; AGING; ARTICLE; COGNITION; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EPISODIC MEMORY; EXECUTIVE FUNCTION; FEMALE; HEALTH STATUS; HUMAN; HUMAN EXPERIMENT; MALE; MEMORY CONSOLIDATION; MENTAL FUNCTION; MENTAL PERFORMANCE; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; VERBAL MEMORY; VITAMIN BLOOD LEVEL; VITAMIN METABOLISM;

AGING; COGNITION; PHYLLOQUINONE; VITAMIN K;

AGED; AGED, 80 AND OVER; AGING; CHOLESTEROL; COGNITION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EXECUTIVE FUNCTION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MEMORY; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; TRIGLYCERIDES; VERBAL BEHAVIOR; VITAMIN K; VITAMIN K 1;

EID: 84884150565     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.05.031     Document Type: Article

References (65)

1. Azharuddin M.K., O'Reilly D.S., Gray A., Talwar D. HPLC method for plasma vitamin K1: effect of plasma triglyceride and acute-phase response on circulating concentrations. Clin. Chem. 2007, 53:1706-1713.
2. Beavan S.R., Prentice A., Stirling D.M., Dibba B., Yan L., Harrington D.J., Shearer M.J. Ethnic differences in osteocalcin gamma-carboxylation, plasma phylloquinone (vitamin K1) and apolipoprotein E genotype. Eur. J. Clin. Nutr. 2005, 59:72-81.
3. Belleville S., Chatelois J., Fontaine F., Peretz I. Mémoria: Batterie informatisée d'évaluation de la mémoire pour Mac et PC 2004, Institut Universitaire de Gériatrie de Montréal, Montréal.
4. Booth S.L., Sokoll L.J., O'Brien M.E., Tucker K., Dawson-Hughes B., Sadowski J.A. Assessment of dietary phylloquinone intake and vitamin K status in postmenopausal women. Eur. J. Clin. Nutr. 1995, 49:832-841.
5. Booth S.L., Tucker K.L., McKeown N.M., Davidson K.W., Dallal G.E., Sadowski J.A. Relationships between dietary intakes and fasting plasma concentrations of fat-soluble vitamins in humans. J.Nutr. 1997, 127:587-592.
6. Canada, H. 2007. Eating well with Canada's Food Guide. © Her Majesty the Queen in Right of Canada, represented by the Minister of Health Canada, HC Publication no. 4651. Catalog no. H164-38/1-2007E.
7. Canada H.W. Nutrition recommendations: The report of the Scientific Review Committee. Minister of Supply and Services Canada 1990, Catalog no. H-49-2/1990E.
8. Carrie I., Belanger E., Portoukalian J., Rochford J., Ferland G. Lifelong low-phylloquinone intake is associated with cognitive impairments in old rats. J.Nutr. 2011, 141:1495-1501.
9. Carrie I., Portoukalian J., Vicaretti R., Rochford J., Potvin S., Ferland G. Menaquinone-4 concentration is correlated with sphingolipid concentrations in rat brain. J.Nutr. 2004, 134:167-172.
10. Cocchetto D.M., Miller D.B., Miller L.L., Bjornsson T.D. Behavioral perturbations in the vitamin K-deficient rat. Physiol. Behav. 1985, 34:727-734.
11. Cohen J.D., MacWhinney B., Flatt M., Provost J. PsyScope: a new graphic interactive environment for designing psychology experiments. Behav. Res. Methods Instrum. Comput. 1993, 25:257-271.
12. Cook Z., Kirk S., Lawrenson S., Sandford S. Use of BMI in the assessment of undernutrition in older subjects: reflecting on practice. Proc. Nutr. Soc. 2005, 64:313-317.
13. Crivello N.A., Casseus S.L., Peterson J.W., Smith D.E., Booth S.L. Age- and brain region-specific effects of dietary vitamin K on myelin sulfatides. J.Nutr. Biochem. 2010, 21:1083-1088.
14. Cutler R.G., Kelly J., Storie K., Pedersen W.A., Tammara A., Hatanpaa K., Troncoso J.C., Mattson M.P. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A 2004, 101:2070-2075.
15. Davidson K.W., Sadowski J.A. Determination of vitamin K compounds in plasma or serum by high-performance liquid chromatography using postcolumn chemical reduction and fluorimetric detection. Methods Enzymol. 1997, 282:408-421.
16. Davis S., Laroche S. Mitogen-activated protein kinase/extracellular regulated kinase signalling and memory stabilization: a review. Genes Brain Behav. 2006, 5(Suppl 2):61-72.
17. Denisova N.A., Booth S.L. Vitamin K and sphingolipid metabolism: evidence to date. Nutr. Rev. 2005, 63:111-121.
18. Erkkila A.T., Lichtenstein A.H., Dolnikowski G.G., Grusak M.A., Jalbert S.M., Aquino K.A., Peterson J.W., Booth S.L. Plasma transport of vitamin K in men using deuterium-labeled collard greens. Metabolism 2004, 53:215-221.
19. Ferland G. Vitamin K and the nervous system: an overview of its actions. Adv. Nutr. 2012, 3:204-212.
20. Gaudreau P., Morais J.A., Shatenstein B., Gray-Donald K., Khalil A., Dionne I., Ferland G., Fulop T., Jacques D., Kergoat M.J., Tessier D., Wagner R., Payette H. Nutrition as a determinant of successful aging: description of the Quebec longitudinal study Nuage and results from cross-sectional pilot studies. Rejuvenation Res. 2007, 10:377-386.
21. Groupe de réflexion sur l'évaluation de la mémoire, Van der Linden M. L'épreuve de rappel libre/rappel indicé à 16 items (RL/RI-16) 2004, 25-47. L'évaluation des troubles de la mémoire: Présentation de quatre tests de mémoire épisodique (avec leur étalonnage), Solal, Marseille.
22. Hall J.G., Pauli R.M., Wilson K.M. Maternal and fetal sequelae of anticoagulation during pregnancy. Am. J. Med. 1980, 68:122-140.
23. He X., Shen L., Bjartell A., Dahlback B. The gene encoding vitamin K-dependent anticoagulant protein S is expressed in multiple rabbit organs as demonstrated by northern blotting, in situ hybridization, and immunohistochemistry. J.Histochem. Cytochem. 1995, 43:85-96.
24. Horwood J.M., Dufour F., Laroche S., Davis S. Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat. Eur. J. Neurosci. 2006, 23:3375-3384.
25. Isaev N.K., Stelmashook E.V., Ruscher K., Andreeva N.A., Zorov D.B. Menadione reduces rotenone-induced cell death in cerebellar granule neurons. Neuroreport 2004, 15:2227-2231.
26. Kohlmeier M., Saupe J., Drossel H.J., Shearer M.J. Variation of phylloquinone (vitamin K1) concentrations in hemodialysis patients. Thromb. Haemost. 1995, 74:1252-1254.
27. Kohlmeier M., Saupe J., Shearer M.J., Schaefer K., Asmus G. Bone health of adult hemodialysis patients is related to vitamin K status. Kidney Int. 1997, 51:1218-1221.
28. Lamon-Fava S., Sadowski J.A., Davidson K.W., O'Brien M.E., McNamara J.R., Schaefer E.J. Plasma lipoproteins as carriers of phylloquinone (vitamin K1) in humans. Am. J. Clin. Nutr. 1998, 67:1226-1231.
29. Li J., Lin J.C., Wang H., Peterson J.W., Furie B.C., Furie B., Booth S.L., Volpe J.J., Rosenberg P.A. Novel role of vitamin K in preventing oxidative injury to developing oligodendrocytes and neurons. J.Neurosci. 2003, 23:5816-5826.
30. Li J., Wang H., Rosenberg P.A. Vitamin K prevents oxidative cell death by inhibiting activation of 12-lipoxygenase in developing oligodendrocytes. J.Neurosci. Res. 2009, 87:1997-2005.
31. McKeown N.M., Jacques P.F., Gundberg C.M., Peterson J.W., Tucker K.L., Kiel D.P., Wilson P.W., Booth S.L. Dietary and nondietary determinants of vitamin K biochemical measures in men and women. J.Nutr. 2002, 132:1329-1334.
32. Morley J.E., Banks W.A. Lipids and cognition. J.Alzheimers. Dis. 2010, 20:737-747.
33. NCEP ATP Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002, 106:3143-3421.
34. Neogi T., Booth S.L., Zhang Y.Q., Jacques P.F., Terkeltaub R., Aliabadi P., Felson D.T. Low vitamin K status is associated with osteoarthritis in the hand and knee. Arthritis Rheum. 2006, 54:1255-1261.
35. Okano T., Shimomura Y., Yamane M., Suhara Y., Kamao M., Sugiura M., Nakagawa K. Conversion of phylloquinone (vitamin K1) into menaquinone-4 (vitamin K2) in mice: two possible routes for menaquinone-4 accumulation in cerebra of mice. J.Biol. Chem. 2008, 283:11270-11279.
36. Presse N., Gaudreau P., Greenwood C.E., Kergoat M.J., Morais J.A., Payette H., Shatenstein B., Ferland G. Asingle measurement of serum phylloquinone is an adequate indicator of long-term phylloquinone exposure in healthy older adults. J.Nutr. 2012, 142:1910-1916.
37. Presse N., Payette H., Shatenstein B., Greenwood C.E., Kergoat M.J., Ferland G. Aminimum of six days of diet recording is needed to assess usual vitamin K intake among older adults. J.Nutr. 2011, 141:341-346.
38. Presse N., Shatenstein B., Kergoat M.J., Ferland G. Low vitamin K intakes in community-dwelling elders at an early stage of Alzheimer's disease. J.Am. Diet. Assoc. 2008, 108:2095-2099.
39. Prieto A.L., O'Dell S., Varnum B., Lai C. Localization and signaling of the receptor protein tyrosine kinase Tyro3 in cortical and hippocampal neurons. Neuroscience 2007, 150:319-334.
40. Prieto A.L., Weber J.L., Tracy S., Heeb M.J., Lai C. Gas6, a ligand for the receptor protein-tyrosine kinase Tyro-3, is widely expressed in the central nervous system. Brain Res. 1999, 816:646-661.
41. Rey A. Test de copie d'une figure complexe 1959, Centre de psychologie appliquée, Manuel, Paris.
42. Ronden J.E., Drittij-Reijnders M.J., Vermeer C., Thijssen H.H. Intestinal flora is not an intermediate in the phylloquinone-menaquinone-4 conversion in the rat. Biochim. Biophys. Acta 1998, 1379:69-75.
43. Sadowski J.A., Hood S.J., Dallal G.E., Garry P.J. Phylloquinone in plasma from elderly and young adults: factors influencing its concentration. Am. J. Clin. Nutr. 1989, 50:100-108.
44. Sakaue M., Mori N., Okazaki M., Kadowaki E., Kaneko T., Hemmi N., Sekiguchi H., Maki T., Ozawa A., Hara S., Arishima K., Yamamoto M. Vitamin K has the potential to protect neurons from methylmercury-induced cell death invitro. J.Neurosci. Res. 2011, 89:1052-1058.
45. Sato Y., Honda Y., Hayashida N., Iwamoto J., Kanoko T., Satoh K. Vitamin K deficiency and osteopenia in elderly women with Alzheimer's disease. Arch. Phys. Med. Rehabil. 2005, 86:576-581.
46. Saupe J., Shearer M.J., Kohlmeier M. Phylloquinone transport and its influence on gamma-carboxyglutamate residues of osteocalcin in patients on maintenance hemodialysis. Am. J. Clin. Nutr. 1993, 58:204-208.
47. Shatenstein B., Nadon S., Godin C., Ferland G. Development and validation of a food frequency questionnaire. Can. J. Diet. Pract. Res. 2005, 66:67-75.
48. Shatenstein B., Nadon S., Godin C., Ferland G. Diet quality of Montreal-area adults needs improvement: estimates from a self-administered food frequency questionnaire furnishing a dietary indicator score. J.Am. Diet. Assoc. 2005, 105:1251-1260.
49. Shea M.K., Benjamin E.J., Dupuis J., Massaro J.M., Jacques P.F., D'Agostino R.B., Ordovas J.M., O'Donnell C.J., Dawson-Hughes B., Vasan R.S., Booth S.L. Genetic and non-genetic correlates of vitamins K and D. Eur. J. Clin. Nutr. 2009, 63:458-464.
50. Sokoll L.J., Sadowski J.A. Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population. Am. J. Clin. Nutr. 1996, 63:566-573.
51. Spreen O., Strauss E. Profile of test results. A compendium of neuropsychological tests: Administration, norms, and commentary 1991, 10-76. Oxford University Press, New York.
52. Spreen O., Strauss E. Acompendium of neuropsychological tests: Administration, norms, and commentary 1998, Oxford University Press, New York. second ed.
53. Sundaram K.S., Fan J.H., Engelke J.A., Foley A.L., Suttie J.W., Lev M. Vitamin K status influences brain sulfatide metabolism in young mice and rats. J.Nutr. 1996, 126:2746-2751.
54. Sundaram K.S., Lev M. Warfarin administration reduces synthesis of sulfatides and other sphingolipids in mouse brain. J.Lipid Res. 1988, 29:1475-1479.
55. Suttie J.W. Vitamin K in Health and Disease 2009, CRC Press Taylor & Francis Group, New York.
56. Thijssen H.H., Drittij-Reijnders M.J. Vitamin K distribution in rat tissues: dietary phylloquinone is a source of tissue menaquinone-4. Br. J. Nutr. 1994, 72:415-425.
57. Thijssen H.H., Drittij-Reijnders M.J. Vitamin K status in human tissues: tissue-specific accumulation of phylloquinone and menaquinone-4. Br. J. Nutr. 1996, 75:121-127.
58. Thijssen H.H., Drittij-Reijnders M.J., Fischer M.A. Phylloquinone and menaquinone-4 distribution in rats: synthesis rather than uptake determines menaquinone-4 organ concentrations. J.Nutr. 1996, 126:537-543.
59. Tsaioun K.I., Denisova N.A., Obin M., Joseph J. Novel growth factor Gas6, phosphatidylserine and their age-related changes in the rat brain. Neurosci. Res. Commun. 2000, 26:113-122.
60. Wang L.Y., Bates C.J., Yan L., Harrington D.J., Shearer M.J., Prentice A. Determination of phylloquinone (vitamin K1) in plasma and serum by HPLC with fluorescence detection. Clin. Chim. Acta 2004, 347:199-207.
61. Washburn R.A., McAuley E., Katula J., Mihalko S.L., Boileau R.A. The Physical Activity Scale for the Elderly (PASE): evidence for validity. J.Clin. Epidemiol. 1999, 52:643-651.
62. Wechsler D. Weschsler Adult Intelligence Scale 1997, Psychological Corporation, San Antonio, TX. Third (WAIS-III) ed.
63. Wisdom N.M., Callahan J.L., Hawkins K.A. The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis. Neurobiol. Aging 2011, 32:63-74.
64. Yan L., Zhou B., Nigdikar S., Wang X., Bennett J., Prentice A. Effect of apolipoprotein E genotype on vitamin K status in healthy older adults from China and the UK. Br. J. Nutr. 2005, 94:956-961.
65. Yesavage J.A., Brink T.L., Rose F.L., Lum O., Huang V., Adey M., Leirer V.O. Development and validation of a geriatric depression screening scale: a preliminary report. J.Psychiatr. Res. 1983, 17:37-49.